The deal adds early-stage candidates for breast, lung, and other tumour types, using RIPTAC technology, to J&J’s pipeline.

Johnson & Johnson (NYSE: JNJ) (the "Company") today announced the successful completion of its acquisition of Halda Therapeutics OpCo, Inc. ("Halda"), a clinical-stage biotechnology company with a ...

Johnson & Johnson has announced the successful completion of its acquisition of Halda Therapeutics OpCo, a clinical-stage ...

Johnson & Johnson completes acquisition of clinical-stage biotechnology company, Halda Therapeutics: New Brunswick, New Jersey Wednesday, December 31, 2025, 12:00 Hrs [IST] Johnso ...

A tiny spider frozen in 100-million-year-old amber is changing what scientists thought they knew about spider evolution. This ...

There are two views of India globally. The first sees India as a future superpower, forming the third pole in an ...

Acquisition brings an advanced, highly differentiated treatment for prostate cancer, strengthening Johnson & Johnson's longstanding commitment to innovation in the disease Lead asset demonstrates pote ...

Genmab A/S announced today that it will discontinue further clinical development of acasunlimab. This decision was made as part of Genmab's strategic focus on the most value?creating opportunities in ...

BTQ Technologies Corp. ("BTQ" or the "Company") (CBOE CA: BTQ) , a global quantum technology company focused on securing mission-critical networks, today issued a Year-End Letter to Shareholders from ...

The Milky Way was once a textbook example of how a spiral galaxy should form and evolve. Now a wave of new observations and ...

Thirty years ago, astronomers weren’t sure planets beyond our solar system even existed. This year, NASA has confirmed its ...

Readers Edition. This is the (nearly) annual tradition of you, RPS readers, telling us where we went wrong in our annual ...